stemcellindex.com takes your privacy seriously. Please read the following to learn more.

* First of all, to help you be more secure when surfing the internet and to guard against internet fraud, secure your computer and protect your personal information. Please learn more from tips that The federal government and technology industry provides click here.

* the server where stemcellindex.com is hosted collects simple information such as your ip address, the referral url, and length of your visit, for statistical use only. We DO NOT collect any personal information such as your name, email address, credit card number, Social Security Number, etc.

* Please note that
- Some or all third party advertisers on this website may use cookies and other technologies such as web beacons to collect information about your visit. To learn more about cookies, and cookies management options, please click here
- stemcellindex.com use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies,
Google ad and content network privacy policy.

Children under age 13 are not allowed to participate, browse, or use the of services provided by this website.

information and content on this website; including comments and opinions... all the content are not necessarily those of Noomle.com. The content and topics on this website are solely the responsibility of the domain\'s owner.

stemcellindex.com may update this policy with or without notifying you about changes in the way we treat personal information.

stemcellindex.com MAKE NO REPRESENTATIONS AS TO THE ACCURACY, QUALITY, TIMELINESS, AVAILABILITY, OR COMPLETENESS OF THE INFORMATION, SOFTWARE, PRODUCTS, ARTICLES OR OTHER MATERIALS AVAILABLE THROUGH stemcellindex.com, AND YOU SHOULD NOT RELY UPON THEM. WE PROVIDE stemcellindex.com; SERVICE, ON AN "AS IS, AS AVAILABLE" BASIS. YOU USE IT AT YOUR OWN RISK, stemcellindex.com IS NOT LIABLE FOR ANY ERRORS OR OMISSIONS IN ITS CONTENT OR DELIVERY, OR FOR ANY FORM OF LOSS OR DAMAGE (INCLUDING ANY CONSEQUENTIAL, INDIRECT, INCIDENTAL, SPECIAL, OR EXEMPLARY DAMAGES, EVEN IF KNOWN TO US) THAT MAY RESULT FROM ITS USE. WE EXPRESSLY DISCLAIM ALL WARRANTIES, INCLUDING WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. NO WARRANTY NOT SET FORTH IN THIS AGREEMENT WILL BE VALID. IF ANY OF THE ABOVE PROVISIONS ARE VOID UNDER GOVERNING LAW, OUR LIABILITY SHALL BE LIMITED TO THE EXTENT PERMITTED BY LAW.


More articles Cell Therapeutics, Inc

More articles Stem Cell Companies

More articles Stem Cell Stocks

More articles BioMimetic Therapeutics (BMTI)

More articles Pluristem Therapeutics-PTSI

More articles Osiris Therapeutics-OSIR

More articles Cytori Therapeutics, Inc.

More articles ThermoGenesis (KOOL)

More articles Nutra Pharma (OTCBB:NPHC)

More articles Human Embryonic Stem Cell Market

More articles RTI Biologics (RTIX)

More articles Aastrom Biosciences -ASTM



XOMA 052 Designated Orphan Drug by FDA ...
Published:Wed, 04 Aug 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Food and Drug Administration has designated XOMA 052, ......
XOMA to Announce 2010 Second Quarter Fi...
Published:Mon, 02 Aug 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of antibody therapeutics, announced that the company will host a webcast conference call on Monday, Augus......
XOMA 052 Orphan Drug Designation for Be...
Published:Thu, 29 Jul 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, announced that the Committee for Orphan Medical Products of the European Medic......
Biotech Stocks: Depomed, Dendreon lead ...
Published:Wed, 04 Aug 2010 07:55:59 -0700
Depomed lead gains among drug stocks a day after it said Pfizer will not file a patent infringement lawsuit to prevent the launch of a painkiller.......
Trader Favorite Dendreon Spikes On Prov...
Published:Wed, 04 Aug 2010 08:00:00 -0700
After soaring higher on the FDA approval of its Provenge prostate cancer vaccine in April, volatile Dendreon quickly retreated to well below its pre-approval pricing, but sales fi......
© 2010 | Privacy Policy | Powered By Noomle.com | SiteMap